Laurel J. Steinherz

3.6k total citations · 1 hit paper
37 papers, 2.7k citations indexed

About

Laurel J. Steinherz is a scholar working on Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Laurel J. Steinherz has authored 37 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 14 papers in Public Health, Environmental and Occupational Health and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Laurel J. Steinherz's work include Chemotherapy-induced cardiotoxicity and mitigation (16 papers), Acute Lymphoblastic Leukemia research (13 papers) and Childhood Cancer Survivors' Quality of Life (11 papers). Laurel J. Steinherz is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (16 papers), Acute Lymphoblastic Leukemia research (13 papers) and Childhood Cancer Survivors' Quality of Life (11 papers). Laurel J. Steinherz collaborates with scholars based in United States, Canada and Poland. Laurel J. Steinherz's co-authors include Peter G. Steinherz, Charlotte Tan, P. Steinherz, Paul A. Meyers, Roger A. Hurwitz, Henry M. Sondheimer, T.P. Graham, Roberta G. Williams, G Sándor and Ronald G. Schwartz and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Laurel J. Steinherz

37 papers receiving 2.6k citations

Hit Papers

Cardiac Toxicity 4 to 20 ... 1991 2026 2002 2014 1991 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cardiac Toxicity 4 to 20 Years After Completing Anthracycline Therapy
    1991 757 citations Laurel J. Steinherz profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurel J. Steinherz United States 22 1.5k 800 682 629 430 37 2.7k
Luis A. Clavell United States 28 1.3k 0.9× 849 1.1× 1.8k 2.6× 1.8k 2.8× 782 1.8× 61 3.9k
Allen R. Chauvenet United States 26 537 0.4× 489 0.6× 649 1.0× 589 0.9× 289 0.7× 64 2.1k
Norma Wollner United States 30 415 0.3× 771 1.0× 619 0.9× 392 0.6× 190 0.4× 65 3.1k
Lucius F. Sinks United States 21 240 0.2× 467 0.6× 353 0.5× 329 0.5× 179 0.4× 51 1.7k
T. Nousiainen Finland 26 483 0.3× 650 0.8× 181 0.3× 71 0.1× 607 1.4× 48 1.7k
Prasad Mathew United States 28 136 0.1× 501 0.6× 325 0.5× 296 0.5× 1.3k 3.0× 90 3.0k
M. Hayat France 33 226 0.1× 1.4k 1.7× 440 0.6× 121 0.2× 989 2.3× 101 3.7k
Arcangelo Prete Italy 32 119 0.1× 826 1.0× 479 0.7× 476 0.8× 1.2k 2.9× 132 3.0k
Aaron C. Logan United States 29 150 0.1× 531 0.7× 491 0.7× 136 0.2× 1.1k 2.6× 117 2.6k
David G. Grenache United States 24 154 0.1× 180 0.2× 281 0.4× 259 0.4× 251 0.6× 87 1.7k

Countries citing papers authored by Laurel J. Steinherz

Since Specialization
Citations

This map shows the geographic impact of Laurel J. Steinherz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurel J. Steinherz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurel J. Steinherz more than expected).

Fields of papers citing papers by Laurel J. Steinherz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurel J. Steinherz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurel J. Steinherz. The network helps show where Laurel J. Steinherz may publish in the future.

Co-authorship network of co-authors of Laurel J. Steinherz

This figure shows the co-authorship network connecting the top 25 collaborators of Laurel J. Steinherz. A scholar is included among the top collaborators of Laurel J. Steinherz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurel J. Steinherz. Laurel J. Steinherz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Modak, Shakeel, et al.. (2015). Trametinib-induced Left Ventricular Dysfunction in a Child With Relapsed Neuroblastoma. Journal of Pediatric Hematology/Oncology. 37(6). e381–e383. 7 indexed citations
2.
Steinherz, Peter G., Neerav Shukla, Rachel Kobos, & Laurel J. Steinherz. (2010). Remission re‐induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia. Pediatric Blood & Cancer. 54(5). 687–693. 13 indexed citations
3.
Jeha, Sima, Bassem I. Razzouk, Michael Rytting, et al.. (2009). Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia. Journal of Clinical Oncology. 27(26). 4392–4397. 58 indexed citations
4.
Steinherz, Peter G., Paul A. Meyers, Laurel J. Steinherz, & Sima Jeha. (2007). Clofarabine Induced Durable Complete Remission in Heavily Pretreated Adolescents With Relapsed and Refractory Leukemia. Journal of Pediatric Hematology/Oncology. 29(9). 656–658. 7 indexed citations
5.
Jeha, Sima, Paul S. Gaynon, Bassem I. Razzouk, et al.. (2006). Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 24(12). 1917–1923. 215 indexed citations
6.
Silber, Jeffrey H., Avital Cnaan, Bernard J. Clark, et al.. (2004). Enalapril to Prevent Cardiac Function Decline in Long-Term Survivors of Pediatric Cancer Exposed to Anthracyclines. Journal of Clinical Oncology. 22(5). 820–828. 210 indexed citations
7.
Heath, John A., Peter G. Steinherz, Arnold J. Altman, et al.. (2003). Human Granulocyte Colony-Stimulating Factor in Children With High-Risk Acute Lymphoblastic Leukemia: A Children’s Cancer Group Study. Journal of Clinical Oncology. 21(8). 1612–1617. 34 indexed citations
8.
Gupta‐Malhotra, Monesha, Peter G. Steinherz, Nai‐Kong V. Cheung, & Laurel J. Steinherz. (2003). Late cardiotoxicity after bolus versus infusion anthracycline therapy for childhood cancers. Medical and Pediatric Oncology. 40(6). 343–347. 24 indexed citations
9.
Gupta‐Malhotra, Monesha, Howard T. Thaler, & Laurel J. Steinherz. (2002). PRESENCE OF PROLONGED DISPERSION OF QT INTERVALS IN LATE SURVIVORS OF CHILDHOOD ANTHRACYCLINE THERAPY. Pediatric Hematology and Oncology. 19(8). 533–542. 18 indexed citations
10.
Heath, John A., Timothy E. Kiehn, Arthur E. Brown, et al.. (2002). Pythium insidiosumPleuropericarditis Complicating Pneumonia in a Child with Leukemia. Clinical Infectious Diseases. 35(6). e60–e64. 22 indexed citations
11.
Silber, Jeffrey H., Avital Cnaan, Bernard J. Clark, et al.. (2001). Design and baseline characteristics for the ACE Inhibitor After Anthracycline (AAA) study of cardiac dysfunction in long-term pediatric cancer survivors. American Heart Journal. 142(4). 577–585. 26 indexed citations
12.
Arndt, Carola A.S., et al.. (1998). A phase II clinical trial of idarubicin administered to children with relapsed brain tumors. Cancer. 83(4). 813–816. 11 indexed citations
13.
LaQuaglia, Michael P., Christopher B. Caldwell, Martin Corbally, et al.. (1994). A prospective randomized double-blind trial of bolus urokinase in the treatment of established Hickman catheter sepsis in children. Journal of Pediatric Surgery. 29(6). 742–745. 34 indexed citations
14.
15.
16.
Steinherz, Laurel J., T.P. Graham, Roger A. Hurwitz, et al.. (1992). Guidelines for Cardiac Monitoring of Children During and After Anthracycline Therapy: Report of the Cardiology Committee of the Childrens Cancer Study Group. PEDIATRICS. 89(5). 942–949. 258 indexed citations
17.
Steinherz, Laurel J. & P. Steinherz. (1991). Delayed cardiac toxicity from anthracycline therapy.. PubMed. 18(1). 49–52. 46 indexed citations
18.
Tan, Charlotte, et al.. (1987). Phase I trial of homoharringtonine in children with refractory leukemia.. PubMed. 71(12). 1245–8. 8 indexed citations
19.
Steinherz, Laurel J.. (1986). Cardiac Involvement in Congenital Acquired Immunodeficiency Syndrome. Archives of Pediatrics and Adolescent Medicine. 140(12). 1241–1241. 45 indexed citations
20.
Steinherz, Laurel J., et al.. (1980). Use of hydralazine for intractable cardiac failure in childhood. The Journal of Pediatrics. 97(6). 1009–1011. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luis A. Clavell Breakdown of academic impact, for papers by Allen R. Chauvenet Breakdown of academic impact, for papers by Norma Wollner Breakdown of academic impact, for papers by Lucius F. Sinks Breakdown of academic impact, for papers by T. Nousiainen Breakdown of academic impact, for papers by Prasad Mathew Breakdown of academic impact, for papers by M. Hayat Breakdown of academic impact, for papers by Arcangelo Prete Breakdown of academic impact, for papers by Aaron C. Logan Breakdown of academic impact, for papers by David G. Grenache
Rankless by CCL
2026